Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis
Anindit Chhibber(University of Utah), David C. Young(University of Notre Dame), Nathorn Chaiyakunapruk(Monash University Malaysia), Diana Brixner(University of Utah), Venkata Yellepeddi(University of Utah), Catherine M.T. Sherwin(Wright State University), Alexandre H. Watanabe(University of Utah), Joseph Biskupiak(University of Utah), M. Sakil Syeed(University of Utah), H. R. D. Jacobs(University of Utah), Aditi Kharat(University of Utah)
Cited by 4
Related Papers
T Cell Activation by Lipopeptide Antigens
|Science|2004|262
Role of Diet in Colorectal Cancer Incidence
|JAMA Network Open|2021|262
Using artificial intelligence methods for systematic review in health sciences: A systematic review
|Research Synthesis Methods|2022|204
Progress toward universal health coverage in ASEAN
|Global Health Action|2014|128
Hypoglycemic Action of Alloxan
|Experimental Biology and Medicine|1937|70